2003
DOI: 10.1016/s0168-8278(03)00333-7
|View full text |Cite
|
Sign up to set email alerts
|

Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
62
0
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 87 publications
(63 citation statements)
references
References 45 publications
0
62
0
1
Order By: Relevance
“…4,5 These proliferating ductules are postulated to arise from hepatic progenitor cells (HPC), [6][7][8] small periportal cells that are bipotential and capable of proliferation and differentiation into both hepatocytes and bile ductular epithelium. They are synonymous with oval cells in the rodent.…”
Section: Abbreviations: Hcv Chronic Hepatitis C; Bmi Body Mass Indementioning
confidence: 99%
“…4,5 These proliferating ductules are postulated to arise from hepatic progenitor cells (HPC), [6][7][8] small periportal cells that are bipotential and capable of proliferation and differentiation into both hepatocytes and bile ductular epithelium. They are synonymous with oval cells in the rodent.…”
Section: Abbreviations: Hcv Chronic Hepatitis C; Bmi Body Mass Indementioning
confidence: 99%
“…These cells are viewed as a progenitor cell type because of their known ability to differentiate into either hepatocytes or biliary epithelial cells (BECs) (1). With the development of improved techniques for detecting oval cells in liver sections, it has become apparent that the oval cell compartment participates in a range of injuries to human liver (2) and may be critical to the survival of patients with acute liver failure (3,4). There are many rodent models for oval cell proliferation.…”
Section: Introductionmentioning
confidence: 99%
“…HPCs are small periportal cells capable of proliferation and differentiation into both hepatocytes and bile ductular epithelium (Clouston et al, 2005;Roskams, 2003). They express stem cell, hepatocyte and bile duct cell markers, including CD133, Nanog, α-Fetoprotein (AFP), CK19, Lin29 and c-Myc (Clouston et al, 2005;Oliva et al, 2010).…”
Section: Cancer Stem Cells 121 Potential Cancer Stem Cellsmentioning
confidence: 99%